Universe Pharmaceuticals Inc (UPC) Financials

UPC Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 53.3 million 13.8 million
2023-09-30 53.3 million 13.8 million
2023-06-30 70.4 million 23.2 million
2023-03-31 70.4 million 23.2 million

UPC Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -3.7 million -984504
2023-09-30 ? ?
2023-06-30 4.8 million 5.0 million
2023-03-31 ? ?

UPC Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2023-12-31 -5.4 million
2023-09-30 -2.7 million
2023-06-30 -715427
2023-03-31 -357714

UPC Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 18.5 million - -
2023-09-30 - - -
2023-06-30 26.3 million - -
2023-03-31 26.3 million - -

UPC Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 3.6 million
2023-09-30 3.6 million
2023-06-30 3.6 million
2023-03-31 3.6 million

UPC Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 43523 2.6 million - -
2023-09-30 - - - -
2023-06-30 646 2.2 million - -
2023-03-31 323 - - -

UPC Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 13.8 million 9.8 million
2023-09-30 - -
2023-06-30 18.5 million 12.5 million
2023-03-31 - -

UPC

Price: $2.15

52 week price:
0.75
5.88

Earnings Per Share: -1.70 USD

P/E Ratio: -0.64

Exchange: NCM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Volume: 21268

Market Capitalization: 6.6 million

Links: